Is Laboratory Corporation of America Holdings (LH) overvalued? · P/E 23, rev $13.01B
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
This page asks whether Laboratory Corporation of America Holdings (LH) looks expensive on cached numbers — not a short thesis.
Latest reported LH revenue for 2024-12-31 was $13.01B. Net income was $747.1M. Revenue was up 7.0% from 2023-12-31 to 2024-12-31. LH currently screens at market cap $21.07B and trailing P/E 22.8.
LH currently screens at market cap $21.07B and trailing P/E 22.8. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next LH 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the LH stock page for the full model, not this heading.
Not investment advice.